The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
C | Cardiovascular system | |
2
|
C10 | Lipid modifying agents | |
3
|
C10A | Lipid modifying agents, plain | |
4
|
C10AD | Nicotinic acid and derivatives |
| Code | Title | |
|---|---|---|
| C10AD01 | Niceritrol | |
| C10AD02 | Nicotinic acid | |
| C10AD03 | Nicofuranose | |
| C10AD04 | Aluminium nicotinate | |
| C10AD05 | Nicotinyl alcohol (pyridylcarbinol) | |
| C10AD06 | Acipimox | |
| C10AD52 | Nicotinic acid, combinations |
| Active Ingredient |
|---|
|
Acipimox inhibits the release of fatty acids from adipose tissue and reduces the blood concentrations of very low density lipoproteins (VLDL or Pre-beta) and low density lipoproteins (LDL or beta) with a subsequent overall reduction in triglyceride and cholesterol levels. |
|
|
|
Niacin (nicotinic acid) is an essential B complex Vitamin (B3), whose deficiency results in the clinical syndrome known as pellagra. Nicotinamide (niacinamide), the active ingredient, is the physiologically active form of niacin and is the chemical form of Vitamin B3 found in virtually all multivitamin products. Though nicotinic acid and nicotinamide are so closely related chemically, they differ somewhat in pharmacological properties. |
| Document | Type | Information Source | |
|---|---|---|---|
| NIASPAN Film coated tablet / Extended-release tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| OLBETAM Capsule | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |